Jennifer Gill
Adult Health · Philadelphia, PANPI 1558784124
Payments from drug & device makers
Across 125 payments — averaging $25.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Daiichi Sankyo Inc.$427
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$254
- Novartis$226
- AstraZeneca$177
- Seagen Inc.$170
- Shield Therapeutics Inc$165
- plus $2K from 30 others
What the payments were for
- Food & beverage$2,89192%
- Education$2658%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Daiichi Sankyo Inc. | 25 | $427 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 11 | $254 |
| Novartis | 10 | $226 |
| AstraZeneca(2 entities) | 8 | $177 |
| Seagen Inc. | 2 | $170 |
| Shield Therapeutics Inc | 3 | $165 |
| Bayer | 3 | $163 |
| Merck | 7 | $156 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $150 |
| Johnson & Johnson(2 entities) | 6 | $148 |
| GSK | 1 | $122 |
| Tolmar, Inc. | 5 | $97 |
| E.r. Squibb & Sons, L.L.C. | 1 | $92 |
| Pharmacosmos Therapeutics Inc. | 3 | $80 |
| Incyte Corporation | 3 | $68 |
| Bristol Myers Squibb | 3 | $63 |
| Eisai Inc. | 2 | $51 |
| AbbVie | 3 | $48 |
| Apellis Pharmaceuticals, Inc. | 2 | $47 |
| Tempus AI, Inc | 2 | $42 |
| Genentech USA, Inc. | 2 | $42 |
| Pharmaand GmbH | 2 | $40 |
| Tersera Therapeutics LLC | 2 | $40 |
| Genmab U.S., Inc. | 1 | $27 |
| Rigel Pharmaceuticals, Inc. | 1 | $27 |
| AVEO Pharmaceuticals, Inc. | 1 | $26 |
| Ipsen Biopharmaceuticals, Inc | 1 | $25 |
| Spectrum Pharmaceuticals Inc. | 1 | $24 |
| Beigene USA, Inc. | 1 | $24 |
| Beone Medicines USA, Inc. | 1 | $22 |
| Fennec Pharmaceuticals, Inc. | 1 | $22 |
| Pharmaessentia USA Corporation | 1 | $21 |
| Sumitomo Pharma America, Inc. | 1 | $20 |
| Boehringer Ingelheim | 1 | $19 |
| Pfizer | 1 | $16 |
| Lilly USA, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INJECTAFER$124
- AREXVY$122
- Nubeqa$108
How this compares
$3,156 in reported general payments places this provider in the 85th percentile of 899 adult health providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JakafiRuxolitinib Phosphate | 13 | $275,049 |
| LynparzaOlaparib | 11 | $184,097 |
| EliquisApixaban | 34 | $28,441 |
| XareltoRivaroxaban | 25 | $22,641 |
| JanuviaSitagliptin Phosphate | 27 | $8,088 |
| Hydroxyurea | 54 | $1,542 |
| Levothyroxine Sodium | 26 | $305 |
| Anastrozole | 20 | $264 |
| Prochlorperazine Maleate | 26 | $225 |
| Morphine Sulfate ErMorphine Sulfate | 14 | $157 |
| Letrozole | 13 | $149 |
| Amlodipine Besylate | 14 | $117 |
| Prednisone | 26 | $104 |
| Atorvastatin Calcium | 14 | $97 |
| Gabapentin | 13 | $96 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Incyte CorporationJakafi | $68 | $275,04913 claims |
| AstraZenecaLynparza | $177 | $184,09711 claims |
| PfizerEliquis | $16 | $28,44134 claims |
| Johnson & JohnsonXarelto | $148 | $22,64125 claims |
| MerckJanuvia | $156 | $8,08827 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 899 adult health providers in Pennsylvania.
Other adult health in Philadelphia
- Beth SandyPhiladelphia$924K
- Diane NewmanPhiladelphia$413K
- Abigail SmithPhiladelphia$302K
- Lauren MassimoPhiladelphia$139K
- Catherine HoldsworthPhiladelphia$64K
- Kevin CarneyPhiladelphia$53K
- Christine ChmielewskiPhiladelphia$52K
- Barbara RogersPhiladelphia$51K
- Joyce RossPhiladelphia$39K
- Veronica RichardsonPhiladelphia$33K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.